Manabu Hayama

Evaluation of safety and tolerability of durvalumab (D) with or without tremelimumab (T) in patients (pts) with biliary tract cancer (BTC).

Tatsuya Ioka, Makoto Ueno, Do‐Youn Oh et al. · Journal of Clinical Oncology · 2019 · 113 citations

Pharmacy, Oncology, Pharmacotherapy +17

Complications with Endobronchial Ultrasound with a Guide Sheath for the Diagnosis of Peripheral Pulmonary Lesions

Manabu Hayama, Takehiro Izumo, Yuji Matsumoto et al. · Respiration · 2015 · 90 citations · Full text

Medicine, Clinical Sciences, Surgery +13

Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head‐and‐neck cancer

Yuichiro Doki, Makoto Ueno, Chih‐Hung Hsu et al. · Cancer Medicine · 2022 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17

Additional transbronchial needle aspiration through a guide sheath for peripheral pulmonary lesions that cannot be detected by radial EBUS

Manabu Hayama, Takehiro Izumo, Christine Chavez et al. · The Clinical Respiratory Journal · 2015 · 27 citations

Medicine, Surgery, Pulmonology +12

Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumors

Yutaka Fujiwara, Haruo Iguchi, Noboru Yamamoto et al. · Cancer Science · 2019 · 26 citations · Full text

Medicine, Oncology, Pharmacology +14